 | • レポートコード：MRC2106A491 • 出版社/出版日：Mordor Intelligence / 2021年5月30日 • レポート形態：英文、PDF、63ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Team User | ￥555,000 (USD3,750) | ▷ お問い合わせ |
| Corporate License | ￥962,000 (USD6,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は、中国のコンパニオンアニマルヘルス市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別分析、診断別分析、動物別分析、競争状況、市場機会/将来の見通しなどを徹底分析したものです。 |
The China Companion Animal Health market was valued at USD 567.28 million in 2020, and it is expected to reach USD 1102.25 million by 2026, registering a CAGR of 11.71% during the forecast period of 2021-2026.
Supply disruption and medicine shortages of veterinary medicines had been observed in China, primarily due to the temporary lockdowns of manufacturing sites, export bans, and increased demand for medicine to treat COVID-19. A slight short-term negative impact is witnessed on companion animal healthcare, primarily due to the reduced veterinary visits, along with the shortage of veterinary medicines, during the outbreak of COVID-19.
The China companion health market is primarily driven by the rising popularity of pet ownership and growing spending on animal healthcare and rising awareness regarding the various treatments available for companion animal diseases.
In recent years, there has been a significant increase in the adoption of dogs and cats that have been observed in China, as they are the most favorite companions of human beings. According to the data of China’s pet industry report in 2019 by online pet forum goumin.com. There are around 99.15 millions of dogs and cats were adopted as pets in the country and dog and cat owners spent a staggering 202 billion yuan (29 billion U.S. dollars) in 2019, an increase of 18.5 percent from the previous year. With the increasing animal population in the country, the demand for vaccination is expected to rise to maintain the companion animals’ proper health. The pet industry in China is booming and the growth rates in the region are comparable to the other developed countries. Hence, the increase in pet adoption has helped in driving the companion health market.
With the increase in the number of companion animals, owners are becoming increasingly aware of their pet’s health and nutrition, and are also seeking veterinary services. This, in turn, is creating a growing demand for diversified forms of companion animal healthcare products.
Furthermore, there are also increasing initiatives by the government and animal welfare association for creating awareness about the various disease against companion animals which will augment the growth of the market as awareness can prevent various animal related disease. 1 INTRODUCTION 2 RESEARCH METHODOLOGY 3 EXECUTIVE SUMMARY 4 MARKET DYNAMICS 5 MARKET SEGMENTATION 6 COMPETITIVE LANDSCAPE 7 MARKET OPPORTUNITIES AND FUTURE TRENDS
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in Pet Adoption, Mostly by Nuclear Families
4.2.2 Increasing in Initiatives by the Governments and Animal Welfare Associations
4.2.3 Advanced Technology in Animal Healthcare
4.3 Market Restraints
4.3.1 Use of Counterfeit Medicines
4.3.2 Increasing Costs of Animal Testing and Veterinary Care
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Products
5.1.1 Therapeutics
5.1.1.1 Vaccines
5.1.1.2 Parasiticides
5.1.1.3 Anti-Infectives
5.1.1.4 Medicinal Feed Additives
5.1.1.5 Other Therapeutics
5.1.2 Diagnostics
5.1.2.1 Immunodiagnostic Tests
5.1.2.2 Molecular Diagnostics
5.1.2.3 Diagnostic Imaging
5.1.2.4 Other Diagnostics
5.2 By Animal Type
5.2.1 Dogs and Cats
5.2.2 Horses
5.2.3 Other Companion Animals
6.1 Company Profiles
6.1.1 China Animal Husbandry Co. Ltd
6.1.2 Dachang
6.1.3 Elanco Animal Health
6.1.4 Merck & Co.
6.1.5 Vetoquinol SA
6.1.6 Virbac
6.1.7 Zoetis Inc.
6.1.8 IDEXX Laboratories, Inc.
6.1.9 Ceva Sant Animale
6.1.10 Pulike Biological Engineering
6.1.11 Tianjin Ringpu Biotechnology Co. Ltd.